| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $885.4M | +1.9% |
| Cost of Revenue | $586.9M | +5.5% |
| Gross Profit | $298.5M | -4.6% |
| R&D Expense | $17.4M | +3.6% |
| SG&A Expense | $133.1M | +1.8% |
| Operating Income | $137.3M | -8.0% |
| Pre-tax Income | $121.8M | -7.1% |
| Income Tax | $23.4M | -12.0% |
| Net Income | $98.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.7M | +53.1% |
| Accounts Receivable | $125.1M | -7.0% |
| Inventory | $191.6M | +15.7% |
| Current Assets | $388.5M | +10.5% |
| Total Assets | $1.46B | +3.4% |
| Current Liabilities | $152.3M | -10.2% |
| Long-term Debt | $446.5M | +0.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $109.9M | -2.9% |
| Capital Expenditures | $31.9M | +19.1% |
| Investing Cash Flow | -$90.8M | -0.6% |
| Financing Cash Flow | -$6.9M | +69.5% |
| Free Cash Flow | $78.0M | -9.7% |
| -5.9% |
| EPS (Basic) | $3.03 | -6.5% |
| EPS (Diluted) | $3.02 | -6.2% |
| Total Liabilities |
| $668.8M |
| -5.3% |
| Stockholders' Equity | $794.9M | +12.1% |